SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (454)2/3/2009 9:09:39 AM
From: rkrw  Read Replies (2) of 508
 
They really ought to be required to repeat capacity 1. 95% powered study showed a .50. But they'll file, maybe they'll have a sympathetic panel. I think the possibility for approval will keep the stock up. The panel will be another massive binary for itmn, even bigger than the data.

Also wondering if there's something fishy in the data, one center or country skewing the outcome of one of the studies for better or for worse. .001 and .5 is just weird.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News